ABSTRACT
INTRODUCTION

Permanent pacemaker implantations have been performed in
Trinidad for several years. The indications have expanded from initially symptomatic bradycardia to now include complex devices which aid in heart failure management, and devices for both the primary and secondary prevention of sudden cardiac death through the prompt and automated termination of episodes of ventricular tachycardia and ventricular fibrillation. Notwithstanding such expanded uses, the local demographics and patterns of implantation have not been recently assessed domestically. We therefore undertook a retrospective review of the available data in an attempt to better understand the evolving trends in device implantation in Trinidad and Tobago including changes in the demographics, indications for pacing and modes of pacing in the Trinidad and Tobago population over the study period.
SUBJECTS AND METHODS
As part of an international registry and data collection process for the World Survey of Cardiac Pacing and Cardioverter-Defibrillators (1, 2) , two years of data were collated from the two major implanting teams in Trinidad for the years 2005 and 2009, respectively, the years for the most recent census. The two implanting centres were the Advanced Cardiovascular Institute (ACI), which is now based at Westshore Medical Centre (formerly at St Clair Medical Centre) and the Catheterization Laboratory of the Eric Williams Medical Sciences Complex (EWMSC). Data were based on retrospective collation using the implantation records. These implantation records are used for both clinical and industry purposes and are mandatory per implant. Each implanting centre is responsible for maintaining its own records. Both centres also use procedure logbooks so that the entered information could be verified with the implantation records. Approval and consent was granted by the relevant departments of both institutions for access to medical records of patients for collection of retrospective data for this study.
Trinidad and Tobago has been a participant of the Heartbeat International Programme since 1985. This is a non-governmental charitable organization responsible for the donation of heart rhythm devices to the indigent populations of the world. Thus, device availability may have been privately purchased by the individual or his insurer, purchased by the state through a public institution or special application subvention, or else may have been donated by Heartbeat International Programme after validation of indigence.
Implantation rates for various countries were taken from The World Survey of Cardiac Pacing and Cardioverterdefibrillators: calendar year 2005 (2) . Economic data were referenced from the online database supplied by the World Bank with comparisons made by creating a novel ratio of implantation rate per million/per capita gross domestic product (GDP) for each territory studied. Attempts were made to select representative countries with both higher and lower GDP ratings than Trinidad and Tobago so as to cater for attributable differences in priority in healthcare spending. The results were presented in descending order of GDP from the United States of America [USA] (highest per capita GDP) to Peru (lowest per capita GDP). surgeons. Training of local implanters was also commenced in the interval between the two samples.
RESULTS
The
The most common indications for new device implants in 2009 were high-degree atrioventricular (AV) block (53%) followed by sick sinus syndrome (22%). (Fig. 3) . Pacing lead insertion for bradycardia indications was done exclusively by the transvenous route (100%). Two cases using combined transvenous and epicardial leads were 
DISCUSSION
Within the last two decades, there has been a dramatic change in the understanding of bradycardia pacing from the simple concept of mortality/morbidity reduction in treating complete heart block with a single chamber pacemaker to understanding the need for both atrio-ventricular and ventricularventricular synchrony in an attempt to imitate the normal cardiac cycle as much as possible. The aim is to reduce heart failure, atrial fibrillation and a potential side effect of the single chamber device, the "pacemaker syndrome" (3, 4). We have also seen the increased use of complex devices to aid in the treatment of advanced heart failure (via CRT-P and CRT-D devices) as well as for the primary and secondary prevention of sudden cardiac death [via AICD devices] (5). On the other hand, these devices come at a substantial cost (6) .
Insertion of implantable devices has been performed for several years in Trinidad. This has been historically successfully performed by varied categories of implanting doctors. Initially, implantations were done by thoracic or cardiothoracic surgeons, especially since sometimes lead implantation required an open thoracotomy for the implantation of epicardial leads. Later, as device and lead size decreased, and as the requirement for epicardial lead positioning became less frequent, cardiologists gradually implanted an increasingly large percentage of devices utilized in treating bradycardias worldwide. More recently, a new category of cardiologists devoted to heart rhythm disturbances has evolved. These electrophysiologists are in short supply worldwide but their importance in developing solutions for patients with tachyarrhythmias is well recognized.
A major improvement has been the increase in physician expertise and education. More internists and general cardiologists are comfortable referring patients for not only the traditional bradycardia devices but for cases where complex devices are indicated. There has also been greater dialogue between the referring physicians and the implanters, allowing appropriate device selection for the clinical needs of the patient. With the local presence of a dedicated full-time electrophysiologist since 2009, and the presence in the pacemaker clinics of the EWMSC of visiting consultants from the Johns Hopkins University under the Trinidad and Tobago Health Science Initiative project, greater cross-education has occurred and will surely continue to drive this process. There has also been a thrust to train the younger physicians in both device implantation and management. With more persons interested in pacing and this continued cross-education, greater skill in programming techniques has developed relevant to the patient's clinical needs eg use of rate response, AAI and DDI pacing modes. This skill has also translated into more frequent use of active lead fixation as well as the multi-disciplinary approach to device management. This includes echocardiography-guided optimization of CRT devices and thoracoscopic implantations of epicardial left ventricular pacing leads in those heart failure patients in whom technical difficulty was encountered during coronary sinus lead placement via the customary transvenous access.
One limitation of the database was the absence of response, by the time of publication, to data requests made to a new group at one implanting site in the 2009 cohort. However, the estimated data error as a consequence of this omission was equivalent to a 4% underestimation in the total number of devices. The inclusion of this data would not have substantially changed the conclusions of this analysis. There would in all probability have been a small increase in the number of devices to just over the 100% increase recorded and virtually no change in the gender distribution or absolute number of complex devices. The data presented therefore minimally underestimates the steady increase in device implantation in Trinidad and Tobago over the interval period. Industry support has also improved now, with on-site expertise for management of Medtronic ™ , St Jude Medical ™ and Boston-Scientific ™ . Programming computers for devices from all major manufacturers are now available. The range of devices, both private and donated, has also expanded, making it possible to choose the best device for the patient's clinical needs in many instances.
Having said such, the implantation rate remains far below rates in developed countries. Notwithstanding better access of patients to health insurance and programmes like Heartbeat International, funding is still a major obstacle to procurement, especially for complex devices which can run in excess of TT$100 000 depending on the type of device, with significant variation amongst manufacturers.
Another challenge is the absence of a clearly articulated policy by the Government of Trinidad and Tobago via Henry et al After excluding countries such as Brazil which would be expected to have a disproportionate device requirement because of the then prevalence of endemic Chagas disease, an infectious cause of heart block, we established a "Propensity Index", obtained by dividing the device implantation rate per million by the per capita GDP for each country under study. Care was taken to sample countries both above and below the economic ranking of Trinidad and Tobago. The 2005 cohort was used since this represented the latest published complete data set for both new device implantation per million and per-capita GDP. Of the eight countries sampled, Trinidad and Tobago scored the lowest (Fig. 5) , confirming an unexplained gap between the economic fortunes of Trinidad and Tobago and its provision of devices when compared with prevailing national efforts globally. For the other seven countries sampled, the Propensity Score for device provision ranged between 1.4 and 13.9 times that of Trinidad and Tobago. Put differently, therefore, when adjusted for economic status and hence presumably the ability to provide, other countries sampled were on average seven times more likely to provide pacemakers and other devices for its citizens than Trinidad and Tobago. A resource-based and rational strategic national philosophy must therefore be developed to address this discrepancy. Perhaps only bradycardia and secondary prevention AICDs should be paid for by the state. We may well need to look at other health systems similar to ours to assess what priorities have been successfully used to determine resource allocation (7) . In addition, local physician consensus should be included to help define policy whenever health economics significantly affect clinical decision making.
In summary, Trinidad and Tobago has been improving with respect to the technical complexity and numbers of rhythm devices implanted in the population, but implantation rates remain far below rates in developed countries even when adjusted for economic status, suggesting that the need remains under-served.
